Wells Fargo & Company »

Galmed Pharmaceuticals shares owned by Wells Fargo & Company

Quarter-by-quarter ownership of Galmed Pharmaceuticals (GLMD) shares owned by Wells Fargo & Company from 13F filings

Historical chart of Wells Fargo & Company investment in Galmed Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Galmed Pharmaceuticals held by Wells Fargo & Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Galmed Pharmaceuticals by Wells Fargo & Company

Quarter filed Position value Share count Share price at filing
2024-03-31 $70 204 0.35
2023-12-31 $93 204 0.46
2023-09-30 $125 204 0.62
2023-06-30 $610 204 2.99